ghk-cu clinical trials Frontiers GHK-Cu — Refined Biolabs

Peptides may be one part of that plan for some people

Although it entered phase 1 trials in consideration as a treatment of ulcerative colitis, it has not been approved by the US Food and Drug Administration (FDA) for medical use, and data on human subjects is lacking

Exercise particular caution with: Blood pressure medications (nitric oxide effects may alter blood pressure) Immunosuppressive drugs (healing modulation could interact) Growth hormone or related medications (receptor interactions possible) Frequently Asked Questions Glossary of Terms References Sikiric P, et al

Therefore, a rat dosage of 10mcg/kg translates to roughly 1.61mcg/kg for human subjects [22]